Schedule 13D ownership disclosure
Aktis Oncology, Inc.
Common Stock · CUSIP: 01021M104
Event date: 2026-01-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLCReported CIK 0001587114
Shares: 4,824,469.00 · Class: 9.1%
- Oleg NodelmanReported CIK 0001454385
Shares: 4,862,335.00 · Class: 9.1%
- EcoR1 Capital Fund Qualified, L.P.Reported CIK 0001598292
Shares: 4,348,658.00 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-26-000046
- Form type
- SCHEDULE 13D
- Filer
- Aktis Oncology, Inc.
- CIK
- CIK 2035832
- Filed
- Jan 20, 2026
- Reporting period
- Jan 12, 2026
- Description
- Schedule 13D beneficial ownership